Q, Z., FS, Y., C, X., CL, L., HT, Y., CM, H., . . . CC, H. (2026). Metformin use and the risk of incident immune-mediated diseases in patients with type 2 diabetes: A population-based cohort study. Frontiers in immunology, 17, 1768882. https://doi.org/10.3389/fimmu.2026.1768882
Chicago Style (17th ed.) CitationQ, Zhang, Yen FS, Xu C, Lin CL, Yip HT, Hwu CM, Wei JC, and Hsu CC. "Metformin Use and the Risk of Incident Immune-mediated Diseases in Patients with Type 2 Diabetes: A Population-based Cohort Study." Frontiers in Immunology 17 (2026): 1768882. https://doi.org/10.3389/fimmu.2026.1768882.
MLA (9th ed.) CitationQ, Zhang, et al. "Metformin Use and the Risk of Incident Immune-mediated Diseases in Patients with Type 2 Diabetes: A Population-based Cohort Study." Frontiers in Immunology, vol. 17, 2026, p. 1768882, https://doi.org/10.3389/fimmu.2026.1768882.